Augmenting the research portfolio and elevating its prominence through enhanced quality and impact.
These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research.
Coronavirus (COVID-19) Update: SMHS Research Re-Start PlansVisit GW SMHS ON CAMPUS Policies and Guidelines website
Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical trials and recognize GW for exceeding its enrollment goals for its vaccine trial.
Anne Chiaramello, PhD, associate professor of anatomy and cell biology and founding director of the Mito-EpiGen Program, discusses the $1.13 million NIH grant she is working on with Andrea Gropman, MD, from Children’s National Hospital, to test a novel therapeutic approach for two rare mitochondrial diseases that occur when mitochondria in cells do not produce enough energy.
The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.
